Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 82

Results For "AI"

8271 News Found

Non-hazardous viral inactivation medium for Covid-19 available in Europe
Medical Device | March 10, 2022

Non-hazardous viral inactivation medium for Covid-19 available in Europe

Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing


Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement
Biotech | March 09, 2022

Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement

Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021


ENTOD Pharmaceuticals launches glaucoma awareness campaign
Public Health | March 08, 2022

ENTOD Pharmaceuticals launches glaucoma awareness campaign

Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease


Dr Sheela Nampoothiri appointed as co-chair of ICMR's Rare Diseases expert committee
People | March 08, 2022

Dr Sheela Nampoothiri appointed as co-chair of ICMR's Rare Diseases expert committee

Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.


Organon declares paid time off for all employees on International Women’s Day
News | March 08, 2022

Organon declares paid time off for all employees on International Women’s Day

As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe


Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
Biotech | March 07, 2022

Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases

Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.


AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
Sustainability | March 07, 2022

AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru

Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation


Lupin signs Mary Kom for its Shakti campaign promoting heart health
Healthcare | March 07, 2022

Lupin signs Mary Kom for its Shakti campaign promoting heart health

The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women


Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
Biotech | March 06, 2022

Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.

Around 85% of ALS patients suffer from a progressive loss of bulbar functionality